TrialHaematologica2018

Sustained efficacy and detailed clinical follow-up of first-line ibrutinib treatment in older patients with chronic lymphocytic leukemia: extended phase 3 results from RESONATE-2.

Paul M Barr et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.